Fighting overdose epidemic, US bans all fentanyl-type drugs

November 9, 2017
Credit: CC0 Public Domain

The US Justice Department on Thursday announced a ban on all fentanyl-like drugs amid skyrocketing rates of overdoses from the synthetic opioids.

Authorities moved to plug legal loopholes in which producers of fentanyl—which can be 50 times more potent than heroin—slightly alter the to render it a legal substance.

"Anyone who possesses, imports, distributes, or manufactures any illicit fentanyl analogue will be subject to criminal prosecution in the same manner as for fentanyl and other controlled substances," the Justice Department said.

The department says some 20,000 of last year's 64,000 can be blamed on fentanyl, either pure or mixed with other drugs such as heroin or prescription opioids.

With the supply of on the market cut back in the past two years, fentanyl has become the cheapest alternative for addicts.

It can be easily bought on the underground internet, and much of it is imported into the country through regular shipping channels, including via the mail and package shippers.

US officials say most of the imported fentanyl comes from China, which Beijing denies.

"The action announced today will make it easier for federal prosecutors and agents to prosecute traffickers of all forms of fentanyl-related substances," the Justice Department said.

Explore further: Fentanyl in more than half of opioid deaths in 10 states

Related Stories

Fentanyl in more than half of opioid deaths in 10 states

October 27, 2017
A federal report says the powerful painkiller fentanyl was involved in more than half of the recent opioid overdose deaths in 10 states.

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

US drug overdose deaths soar in 2016: report

June 6, 2017
US drug overdose deaths surged 19 percent to at least 59,000 last year as deadly manufactured drugs like fentanyl intensified a national opioid addiction crisis, New York Times data showed Tuesday.

US health chief lauds China for help with opioid control

August 21, 2017
China has been an "incredible partner" in cracking down on synthetic opioids seen as fueling fast-rising overdose deaths in the United States, U.S. Health and Human Services Secretary Tom Price said Monday during a visit ...

Five things to know about America's synthetic-opioid epidemic

December 21, 2016
Government scientists say they're seeing the emergence of a new class of deadly drugs built to mimic the potent prescription painkiller fentanyl. What you need to know:

Canada says it will restrict fentanyl chemicals

September 1, 2016
Canada plans to restrict six chemicals used to make the drug fentanyl in a bid to stem what it called a national opioid crisis, the Canadian health minister said Wednesday.

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.